(NASDAQ: NMTC) Neuroone Medical Technologies's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 21.72%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 19.94%.
Neuroone Medical Technologies's earnings in 2025 is -$6,603,405.On average, 1 Wall Street analyst forecast NMTC's earnings for 2025 to be -$6,476,319, with the lowest NMTC earnings forecast at -$6,476,319, and the highest NMTC earnings forecast at -$6,476,319. On average, 1 Wall Street analyst forecast NMTC's earnings for 2026 to be -$7,472,675, with the lowest NMTC earnings forecast at -$7,472,675, and the highest NMTC earnings forecast at -$7,472,675.
In 2027, NMTC is forecast to generate -$5,479,962 in earnings, with the lowest earnings forecast at -$5,479,962 and the highest earnings forecast at -$5,479,962.